Jnba Financial Advisors Novo Nordisk A S Transaction History

Jnba Financial Advisors

$970 Million
Q4 2024

A detailed history of Jnba Financial Advisors transactions in Novo Nordisk A S stock. As of the latest transaction made, Jnba Financial Advisors holds 1,986 shares of NVO stock, worth $170,259. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,986

Previous 2,187 9.19%

Holding current value

$170,259

Previous $260,000 34.62%

% of portfolio

0.02%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	SELL	$85.0 - $120.04 $17,085 - $24,128	-201 Reduced 9.19%	1,986 $170,000
Q3 2024 Oct 30, 2024	SELL	$119.07 - $145.42 $238,140 - $290,840	-2,000 Reduced 47.77%	2,187 $260,000
Q2 2024 Jul 22, 2024	SELL	$122.71 - $146.91 $170,198 - $203,764	-1,387 Reduced 24.88%	4,187 $597,000
Q1 2024 Apr 26, 2024	BUY	$102.11 - $135.92 $16,746 - $22,290	164 Added 3.03%	5,574 $715,000
Q4 2023 Feb 07, 2024	SELL	$87.78 - $105.45 $13,869 - $16,661	-158 Reduced 2.84%	5,410 $559,000
Q3 2023 Nov 02, 2023	BUY	$90.94 - $199.54 $253,176 - $555,519	2,784 Added 100.0%	5,568 $506,000
Q1 2023 May 01, 2023	SELL	$132.34 - $159.14 $3,308 - $3,978	-25 Reduced 0.89%	2,784 $443,000
Q4 2022 Feb 06, 2023	SELL	$102.55 - $135.33 $260,477 - $343,738	-2,540 Reduced 47.49%	2,809 $380,000
Q3 2022 Nov 07, 2022	SELL	$95.28 - $116.93 $115,574 - $141,836	-1,213 Reduced 18.49%	5,349 $533,000
Q2 2022 Jul 22, 2022	SELL	$103.24 - $121.81 $11,356 - $13,399	-110 Reduced 1.65%	6,562 $731,000
Q4 2020 Jan 25, 2021	BUY	$63.89 - $73.8 $19,167 - $22,140	300 Added 4.71%	6,672 $466,000
Q2 2019 Jul 26, 2019	BUY	$46.79 - $52.47 $30,179 - $33,843	645 Added 11.26%	6,372 $325,000
Q1 2019 May 01, 2019	BUY	$46.36 - $52.63 $242,323 - $275,097	5,227 Added 1045.4%	5,727 $300,000
Q4 2018 Feb 07, 2019	BUY	$41.54 - $47.25 $20,770 - $23,625	500 New	500 $23,000
Q3 2018 Nov 01, 2018	SELL	$46.76 - $51.24 $23,380 - $25,620	-500 Closed	0 $0
Q1 2018 May 07, 2018	SELL	$48.49 - $58.14 $30,063 - $36,046	-620 Reduced 55.36%	500 $500,000
Q3 2017 Nov 13, 2017	SELL	$41.15 - $49.22 $81,435 - $97,406	-1,979 Reduced 63.86%	1,120 $54,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,099	3,099 $133,000

Others Institutions Holding NVO

# of Institutions

1,870

Shares Held

317M

Call Options Held

5.49M

Put Options Held

7.77M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $194B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Jnba Financial Advisors with notifications on news.

Account

Jnba Financial Advisors Novo Nordisk A S Transaction History